Early-stage research suggests intranasal dihexa may achieve therapeutic CNS concentrations with minimal systemic exposure, potentially extending the effective half life at the target site (hippocampus) while reducing plasma half life
[DOI] [PubMed] [Google Scholar] Castelli MC, Wong D, Friedman K, Bhargava P, Riley GM
Restore Vitality From the Inside Out When your body has the right tools, it can heal, repair, and thrive
Integrative PeptidesBPC-157is a naturally occurring peptide that has been found to support connective tissue healing
These studies have generally demonstrated positive therapeutic outcomes, but translation to clinical applications requires careful consideration of species differences and experimental limitations
The link between COVID-19 vaccinations and Sneddon Wilkinson Disease (Sneddon Syndrome) is one such worry that has drawn attention